Provided by Tiger Fintech (Singapore) Pte. Ltd.

Myriad Genetics

7.64
-0.2700-3.41%
Post-market: 7.640.00000.00%16:20 EDT
Volume:1.61M
Turnover:12.31M
Market Cap:697.60M
PE:-5.42
High:7.93
Open:7.86
Low:7.58
Close:7.91
Loading ...

Myriad Genetics price target lowered to $24 from $30 at Piper Sandler

TIPRANKS
·
11 Nov 2024

Myriad Genetics: Overcoming Setbacks with Strategic Resilience and Growth Prospects

TIPRANKS
·
11 Nov 2024

Myriad Genetics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.
·
09 Nov 2024

Myriad Genetics Reports Solid Q3 2024 Growth Amid Challenges

TIPRANKS
·
09 Nov 2024

Stock Track | Myriad Genetics Soars on Impressive Q3 Results, Upbeat Outlook

Stock Track
·
08 Nov 2024

Stock Track | Myriad Genetics Soars on Q3 Earnings Beat, Robust Growth Outlook

Stock Track
·
08 Nov 2024

Myriad Genetics price target lowered to $20 from $30 at TD Cowen

TIPRANKS
·
08 Nov 2024

MYGN Beats on Q3 Earnings and Revenues, Raises '24 EPS View

Zacks
·
08 Nov 2024

Myriad Genetics Inc : Leerink Partners Cuts Target Price to $30 From $40

THOMSON REUTERS
·
08 Nov 2024

Myriad Genetics Inc (MYGN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Policy ...

GuruFocus.com
·
08 Nov 2024

Myriad Genetics Inc reports results for the quarter ended in September 30 - Earnings Summary

Reuters
·
08 Nov 2024

Myriad Genetics Q3 2024 Adj. EPS $0.06 Beats $0.02 Estimate, Sales $213.300M Beat $210.729M Estimate

Benzinga
·
08 Nov 2024

BRIEF-Myriad Genetics Q3 Operating Income USD -20 Million

Reuters
·
08 Nov 2024

Myriad Genetics : Continues to Pursue a Resolution With Unh That Allows for Its Commercial Enrollees to Continue to Have Access to Genesight Test

THOMSON REUTERS
·
08 Nov 2024

Myriad Genetics Inc Outlook FY REV $837 Mln - $843 Mln, & Adj EPS of $0.12 - $0.14

THOMSON REUTERS
·
08 Nov 2024

Myriad Genetics Q3 Operating Expenses USD 169.8 Million

THOMSON REUTERS
·
08 Nov 2024

BIIB vs. MYGN: Which Stock Is the Better Value Option?

Zacks
·
07 Nov 2024

Myriad Genetics in Active Talks with UnitedHealthcare to Keep Coverage of GeneSight

Dow Jones
·
05 Nov 2024

Myriad Genetics Disputes Inclusion of GeneSight in UnitedHealthcare's Coverage Restriction

MT Newswires Live
·
04 Nov 2024

Myriad Genetics comments on UnitedHealthcare’s updated policy

TIPRANKS
·
04 Nov 2024